閉塞安定化インテグリン阻害剤を作るための一般的な化学原理
Fu-Yang Lin1, Jing Li1, Yonghua Xie2
1Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Cell
|September 16, 2022
まとめ
小分子インテグリン阻害剤は,活性構造を安定させることで失敗することがあります. 新たに特定された化学的特徴である極性窒素原子は,代わりに不活性なインテグリン構造を安定させ,新しい薬剤設計戦略を提供します.
科学分野:
- 生物化学
- 薬理学について
- 構造生物学
背景:
- インテグリンは重要な薬物標的であり,承認された治療法があります.
- 前回のインテグリン小分子阻害剤 (αIIbβ3,α4β1) は慢性疾患の末期試験で失敗した.
- 高親和性インテグリン状態を安定させる部分的アゴニズムは,これらの失敗の潜在的な原因である.
研究 の 目的:
- 小分子インテグリン阻害剤が臨床試験で失敗した理由を調査する.
- インテグリン抑制の基礎となる構造的メカニズムを特定する.
- 効果的なインテグリン対抗剤の開発のための新薬設計原理を発見する.
主な方法:
- インテグリン構造を評価する生化学的測定法
- インテグリンに結合する小分子阻害剤の構造分析.
- 主要な化学特性を特定するための構造-活性関係の研究.
主要な成果:
- インテグリンαIIbβ3およびα4β1の小分子阻害剤の失敗は,高親和性,拡張オープン構造を安定させることが判明しました.
- αIIbβ3抗体における新しい化学特性 (極性窒素原子) が識別され,曲げ閉じた低親和形状を安定させる.
- この安定化には,金属イオン依存粘着部位 (MIDAS) の水分子が関与し,開いた状態への移行を防止します.
結論:
- 活性構造を安定させる部分的アゴニズムは,いくつかのインテグリン阻害剤の失敗に寄与する.
- 単純な化学的特徴である極性窒素は,不活性なインテグリン構造を安定させる阻害剤を設計するために利用できます.
- この薬剤設計原理は,α4β1インテグリンで示されたように,インテグリンファミリー全体に広く適用可能である.
さらに関連する動画
09:45Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
10.7K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
関連する概念動画
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:15Activation of Integrins
3.6K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.6K
01:10Integrins
4.1K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.1K
01:30Enzyme Inhibition
79.1K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.1K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.5K